Protagonist Therapeutics Inc (PTGX)
41.69
+1.04
(+2.56%)
USD |
NASDAQ |
Nov 21, 16:00
41.69
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Price to Book Value: 4.671 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.555 |
| November 19, 2024 | 4.330 |
| November 18, 2024 | 4.526 |
| November 15, 2024 | 4.606 |
| November 14, 2024 | 4.598 |
| November 13, 2024 | 4.781 |
| November 12, 2024 | 4.837 |
| November 11, 2024 | 5.210 |
| November 08, 2024 | 5.180 |
| November 07, 2024 | 5.334 |
| November 06, 2024 | 5.333 |
| November 05, 2024 | 5.143 |
| November 04, 2024 | 5.239 |
| November 01, 2024 | 5.239 |
| October 31, 2024 | 5.136 |
| October 30, 2024 | 5.329 |
| October 29, 2024 | 5.419 |
| October 28, 2024 | 5.394 |
| October 25, 2024 | 5.288 |
| October 24, 2024 | 5.254 |
| October 23, 2024 | 5.214 |
| October 22, 2024 | 5.197 |
| October 21, 2024 | 5.143 |
| October 18, 2024 | 5.256 |
| October 17, 2024 | 5.262 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.258 |
| October 15, 2024 | 5.331 |
| October 14, 2024 | 5.187 |
| October 11, 2024 | 5.044 |
| October 10, 2024 | 4.878 |
| October 09, 2024 | 4.944 |
| October 08, 2024 | 4.919 |
| October 07, 2024 | 4.901 |
| October 04, 2024 | 4.965 |
| October 03, 2024 | 4.962 |
| October 02, 2024 | 5.033 |
| October 01, 2024 | 4.965 |
| September 30, 2024 | 5.036 |
| September 27, 2024 | 4.849 |
| September 26, 2024 | 4.889 |
| September 25, 2024 | 5.021 |
| September 24, 2024 | 5.069 |
| September 23, 2024 | 5.022 |
| September 20, 2024 | 5.150 |
| September 19, 2024 | 4.997 |
| September 18, 2024 | 4.872 |
| September 17, 2024 | 4.887 |
| September 16, 2024 | 5.027 |
| September 13, 2024 | 5.116 |
| September 12, 2024 | 4.967 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.138
Minimum
Jun 13 2022
11.04
Maximum
Jun 25 2020
4.086
Average
4.009
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.336 |
| Assembly Biosciences Inc | 3.615 |
| Precision BioSciences Inc | 0.7699 |
| Entrada Therapeutics Inc | 1.601 |
| NovaBay Pharmaceuticals Inc | 3.291 |
Price to Book Value Related Metrics
| PE Ratio | 15.67 |
| PS Ratio | 7.954 |
| Price to Free Cash Flow | 11.23 |
| Price | 41.69 |
| Earnings Yield | 6.38% |
| Market Cap | 2.485B |
| Operating PE Ratio | 17.27 |
| Normalized PE Ratio | 15.67 |